Related Experiment Video
Updated: May 25, 2026

08:36
In Vivo Imaging to Measure Spontaneous Lung Metastasis of Orthotopically-injected Breast Tumor Cells
Published on: June 23, 2022
[The metastatic process: history, models and recent advances].
François-Clément Bidard1, Marie-France Poupon
1Département D'oncologie Médicale, Institut Curie, 26 rue d'Ulm, 75005 Paris, France. fcbidard@curie.fr
Summary
Cancer metastasis, the spread of cancer cells, leads to poor outcomes. Understanding its steps, like epithelial-mesenchymal transition and circulating tumor cells, is key to improving patient survival.
Area of Science:
- Oncology
- Cancer Biology
- Cellular Biology
Context:
- Metastasis is a critical event in cancer progression.
- It is strongly associated with poor clinical outcomes.
- The metastatic process involves multiple, distinct biological steps.
Purpose:
- To review current understanding of cancer metastasis mechanisms.
- To highlight proposed models of metastasis.
- To identify future research directions in metastasis.
Summary:
- The metastatic cascade comprises several well-characterized, distinct biological steps.
- Explanatory models include clonal selection, adaptive oncogenesis, tumor stem cells, and epithelial-mesenchymal transition.
- Characterizing circulating and disseminated tumor cells offers new insights into patient metastasis.
Impact:
- Improved understanding of metastasis can lead to better clinical outcomes.
- Focusing on circulating and disseminated tumor cells may reveal novel therapeutic targets.
- Advances in metastasis research are crucial for developing more effective cancer treatments.
Related Concept Videos
Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

